Immunomodulatory therapy of cytomegalovirus pneumonia after liver transplantation
- Author:
- No author available
- Journal Title:
- CHINESE MEDICAL JOURNAL
- Issue:
- 17
- DOI:
- No doi available
- Key Word:
- liver transplantation;cytomegalovirus pneumonia;immunotherapy
Abstract： Background There has been increasing interest in the research into cytomegalovirus (CMV) pneumonia after liver transplantation (LT). This study was undertaken to investigate the immunomodulatory therapy of CMV pneumonia after LT.Methods Six patients with CMV pneumonia after LT from October 2003 to November 2005 were analyzed retrospectively. They were diagnosed according to clinical manifestations, chest X-ray findings and pathogenic changes and given comprehensive therapy including mainly immunomodulation therapy and anti-viral medication. At the early stage of CMV pneumonia, the dose of immunosuppressive agents was decreased or ceased, instead replaced by immunoenhancement therapy. During recovery period from CMV pneumonia, the dose of immunosuppressive agents was given again or enhanced, and immunoenhancement therapy was ceased.The liver function of the patients was monitored closely during the treatment.Results In this series, five patients were survived and one died. The liver function of the six patients remained normal during the treatment, and no episode of acute rejection took place.Conclusions Poor immunity is the pathogenic basis of CMV pneumonia after LT. At early stage of CMV pneumonia, the immunity of the patients should be enhanced, and during the recovery period from CMV pneumonia, immunosuppresants shoud be given again but immunoenhancement therapy ceased. Individualized immunomodulatory therapy is essential to the treatment of CMV pneumonia after LT.
- [1]HEI Zi-qing,LIU De-zhao,LUO Chen-fang,etc.Perioperative changes of ventricular function and three indicators of myocardial injury during orthotopic liver transplantation[J].2006,(11).
- [2]汪根树,李华,陈规划,等.肝移植术后巨细胞病毒肺炎的诊断和治疗[J].2005,(23).
- [3]MA Yu-kui,YAN Lü-nan,LI Bo,etc.Diagnosis and treatment of bacterial pneumonia in liver transplantation recipients: report of 33 cases[J].2005,(22).
- [4]Daniel, Seehofer,Nada, Rayes,Ulf P, Neumann,etc.Changing impact of cytomegalovirus in liver transplantation -- a single centre experience of more than 1000 transplantations without ganciclovir prophylaxis.[J].2005,18.
- [5]J W, Hadden,A, Saha,M, Sosa,etc.Immunotherapy with natural interleukins and/or thymosin alpha 1 potently augments T-lymphocyte responses of hydrocortisone-treated aged mice.[J].1995,17.
- [6]Jones TR,Nelson JA,Tomazin R,etc.Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells.[J].1999,5(9).
- [7]Nichols WG,Boeckh M.Recent advances in the therapy and prevention of CMV infections.[J].2000,16(1).
- [8]David Mutimer.CMV Infection of transplant Recipients[J].1996,25(2).
- [9]Wiedeman JA.,Lunetta JM..Latency-associated sense transcripts are expressed during in vitro human cytomegalovirus productive infection[J].2000,278(2).
- [10]Shanker A,Singh SM,Roy R.Mechanism of thymocyte apoptosis induced by serum of tumor-bearing host: the molecular events involved and their inhibition by thymosin alpha-1.[J].2000,22(4).
- [11]Soderberg-Naucler C,Odeberg J.Reduced expression of HLA class II molecules and Iinterleukin-10- and transforming growth factor beta1-independent suppression of T-cell proliferation in human cytomegalovirus-infected macrophage cultures.[J].2001,75(11).
- [12]M B, Sztein,S A, Serrate,A L, Goldstein.Modulation of interleukin 2 receptor expression on normal human lymphocytes by thymic hormones.[J].1986,83.
- [13]E F, de Maar,E A M, Verschuuren,M C, Harmsen,etc.Pulmonary involvement during cytomegalovirus infection in immunosuppressed patients.[J].2003,5(3).
- [14]Prod'homme V,Bonneville M,Retiere C,etc.Generation of cytomegalovirus-specific human T-lymphocyte clones by using autologous B-lymphoblastoid cells with stable expression of pp65 or IE1 proteins: a tool to study the fine specificity of the antiviral response.[J].2000,74(9).
- [15]Adriaanse HM,Dekkers CA,Greijer AE,etc.Expression dynamics of human cytomegalovirus immune evasion genes US3, US6, and US11 in the blood of lung transplant recipients.[J].2001,184(3).
- [16]J, Hsia,M B, Sztein,P H, Naylor,etc.Modulation of thymosin alpha 1 and thymosin beta 4 levels and peripheral blood mononuclear cell subsets during experimental rhinovirus colds.[J].1989,8.
- [17]M, Ho.Advances in understanding cytomegalovirus infection after transplantation.[J].1994,26(5 Suppl 1).